{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T09:52:37Z","timestamp":1769248357190,"version":"3.49.0"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/4950\/2025"],"award-info":[{"award-number":["UID\/4950\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-026-00763-z","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:43:08Z","timestamp":1769013788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histone and non-histone (de)acetylation impact on the blood-brain barrier"],"prefix":"10.1186","volume":"23","author":[{"given":"Mariana","family":"Melo","sequence":"first","affiliation":[]},{"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Laranjinha","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Bicker","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"763_CR1","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","volume":"282","author":"J Keaney","year":"2015","unstructured":"Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J. 2015;282:4067\u201379.","journal-title":"FEBS J"},{"key":"763_CR2","doi-asserted-by":"crossref","unstructured":"Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7.","DOI":"10.1101\/cshperspect.a020412"},{"key":"763_CR3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41586-025-08589-9","volume":"639","author":"SM Shi","year":"2025","unstructured":"Shi SM, Suh RJ, Shon DJ, Garcia FJ, Buff JK, Atkins M, et al. Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease. Nature. 2025;639:985\u201394.","journal-title":"Nature"},{"key":"763_CR4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/s41593-021-00904-7","volume":"24","author":"S Schaeffer","year":"2021","unstructured":"Schaeffer S, Iadecola C. Revisiting the neurovascular unit. Nat Neurosci. 2021;24:1198\u2013209.","journal-title":"Nat Neurosci"},{"key":"763_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"},{"key":"763_CR6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","volume":"36","author":"NJ Abbott","year":"2013","unstructured":"Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013;36:437\u201349.","journal-title":"J Inherit Metab Dis"},{"key":"763_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tins.2020.12.002","volume":"44","author":"M Segarra","year":"2021","unstructured":"Segarra M, Aburto MR, Acker-Palmer A. Blood\u2013Brain barrier dynamics to maintain brain homeostasis. Trends Neurosci. 2021;44:393\u2013405.","journal-title":"Trends Neurosci"},{"key":"763_CR8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tins.2019.05.001","volume":"42","author":"VA Cuddapah","year":"2019","unstructured":"Cuddapah VA, Zhang SL, Sehgal A. Regulation of the Blood\u2013Brain barrier by circadian rhythms and sleep. Trends Neurosci. 2019;42:500\u201310.","journal-title":"Trends Neurosci"},{"key":"763_CR9","doi-asserted-by":"crossref","unstructured":"Fong H, Zhou B, Feng H, Luo C, Bai B, Zhang J, et al. Recapitulation of structure-function-regulation of blood-brain barrier under (patho) physiological conditions. Cells. 2024;13.","DOI":"10.3390\/cells13030260"},{"key":"763_CR10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1074\/jbc.R116.760215","volume":"292","author":"HL McConnell","year":"2017","unstructured":"McConnell HL, Kersch CN, Woltjer RL, Neuwelt EA. The translational significance of the neurovascular unit. J Biol Chem. 2017;292:762\u201370.","journal-title":"J Biol Chem"},{"key":"763_CR11","doi-asserted-by":"crossref","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 2020;17.","DOI":"10.1186\/s12987-020-00230-3"},{"key":"763_CR12","first-page":"1","volume":"22","author":"I Wilhelm","year":"2025","unstructured":"Wilhelm I, Gy\u0151ri F, Dud\u00e1s T, Nagy V, Shreeya T, Krecsmarik M, et al. Eppur Si muove: the dynamic brain pericyte. Fluids Barriers CNS 2025. 2025;22:1.","journal-title":"Fluids Barriers CNS 2025"},{"key":"763_CR13","doi-asserted-by":"crossref","unstructured":"Ihezie SA, Mathew IE, McBride DW, Dienel A, Blackburn SL. Thankamani Pandit PK. Epigenetics in blood-brain barrier disruption. Fluids Barriers CNS 2021;18.","DOI":"10.1186\/s12987-021-00250-7"},{"key":"763_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","volume":"46","author":"B D\u00edaz-Castro","year":"2023","unstructured":"D\u00edaz-Castro B, Robel S, Mishra A. Astrocyte endfeet in brain function and pathology: open questions. Annu Rev Neurosci. 2023;46:101\u201321.","journal-title":"Annu Rev Neurosci"},{"key":"763_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2014.05.021","volume":"73","author":"CF Louren\u00e7o","year":"2014","unstructured":"Louren\u00e7o CF, Santos RM, Barbosa RM, Cadenas E, Radi R, Laranjinha J. Neurovascular coupling in hippocampus is mediated via diffusion by neuronal-derived nitric oxide. Free Radic Biol Med. 2014;73:421\u20139.","journal-title":"Free Radic Biol Med"},{"key":"763_CR16","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia States and nomenclature: A field at its crossroads. Neuron. 2022;110:3458\u201383.","journal-title":"Neuron"},{"key":"763_CR17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987\u201391.","journal-title":"Nat Neurosci"},{"key":"763_CR18","doi-asserted-by":"crossref","unstructured":"Bicker J, Alves G, Fonseca C, Falc\u00e3o A, Fortuna A. Repairing blood-CNS barriers: future therapeutic approaches for neuropsychiatric disorders. Pharmacol Res. 2020;162.","DOI":"10.1016\/j.phrs.2020.105226"},{"key":"763_CR19","doi-asserted-by":"crossref","unstructured":"Lemarchant S, Engelhardt B, Cicchetti F, Bix GJ, Janus A, Godfrin Y, et al. Restoring brain barriers: an innovative approach for treating neurological disorders. Fluids Barriers CNS 2025;22.","DOI":"10.1186\/s12987-025-00688-z"},{"key":"763_CR20","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1073\/pnas.1914655117","volume":"117","author":"KA Dudek","year":"2020","unstructured":"Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, et al. Molecular adaptations of the blood\u2013brain barrier promote stress resilience vs. Depression. Proc Natl Acad Sci U S A. 2020;117:3326\u201336.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"763_CR21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3233\/JAD-180259","volume":"64","author":"M Zusso","year":"2018","unstructured":"Zusso M, Barbierato M, Facci L, Skaper SD, Giusti P. Neuroepigenetics and alzheimer\u2019s disease: an update. J Alzheimers Dis. 2018;64:671\u201388.","journal-title":"J Alzheimers Dis"},{"key":"763_CR22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cmet.2019.03.009","volume":"29","author":"C Ling","year":"2019","unstructured":"Ling C, R\u00f6nn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019;29:1028\u201344.","journal-title":"Cell Metab"},{"key":"763_CR23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s12272-017-0973-3","volume":"40","author":"QA Abdul","year":"2017","unstructured":"Abdul QA, Yu BP, Chung HY, Jung HA, Choi JS. Epigenetic modifications of gene expression by lifestyle and environment. Arch Pharm Res. 2017;40:1219\u201337.","journal-title":"Arch Pharm Res"},{"key":"763_CR24","first-page":"669","volume":"128","author":"BE Bernstein","year":"2007","unstructured":"Bernstein BE, Meissner A, Lander ES. Mammalian Epigenome Cell. 2007;128:669\u201381.","journal-title":"Mammalian Epigenome Cell"},{"key":"763_CR25","doi-asserted-by":"crossref","unstructured":"Almouzni G, Cedar H. Maintenance of epigenetic information. Cold Spring Harb Perspect Biol. 2016;8.","DOI":"10.1101\/cshperspect.a019372"},{"key":"763_CR26","doi-asserted-by":"crossref","unstructured":"Massart R, Freyburger M, Suderman M, Paquet J, El Helou J, Belanger-Nelson E, et al. The genome-wide landscape of DNA methylation and hydroxymethylation in response to sleep deprivation impacts on synaptic plasticity genes. Transl Psychiatry. 2014;4.","DOI":"10.1038\/tp.2013.120"},{"key":"763_CR27","doi-asserted-by":"crossref","unstructured":"Henshall DC, Kobow K. Epigenetics and epilepsy. Cold Spring Harb Perspect Med. 2015;5.","DOI":"10.1101\/cshperspect.a022731"},{"key":"763_CR28","doi-asserted-by":"crossref","unstructured":"Toden S, Zumwalt TJ, Goel A. Non-coding RNAs and potential therapeutic targeting in cancer. Biochim Biophys Acta Rev Cancer. 2021;1875.","DOI":"10.1016\/j.bbcan.2020.188491"},{"key":"763_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.03.002","volume":"65","author":"X Corso-D\u00edaz","year":"2018","unstructured":"Corso-D\u00edaz X, Jaeger C, Chaitankar V, Swaroop A. Epigenetic control of gene regulation during development and disease: A view from the retina. Prog Retin Eye Res. 2018;65:1\u201327.","journal-title":"Prog Retin Eye Res"},{"key":"763_CR30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s13238-020-00733-7","volume":"11","author":"LY Zhao","year":"2020","unstructured":"Zhao LY, Song J, Liu Y, Song CX, Yi C. Mapping the epigenetic modifications of DNA and RNA. Protein Cell. 2020;11:792\u2013808.","journal-title":"Protein Cell"},{"key":"763_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","volume":"131","author":"R Lardenoije","year":"2015","unstructured":"Lardenoije R, Iatrou A, Kenis G, Kompotis K, Steinbusch HWM, Mastroeni D, et al. The epigenetics of aging and neurodegeneration. Prog Neurobiol. 2015;131:21\u201364.","journal-title":"Prog Neurobiol"},{"key":"763_CR32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/15592294.2019.1666649","volume":"15","author":"K Fu","year":"2020","unstructured":"Fu K, Bonora G, Pellegrini M. Interactions between core histone marks and DNA methyltransferases predict DNA methylation patterns observed in human cells and tissues. Epigenetics. 2020;15:272\u201382.","journal-title":"Epigenetics"},{"key":"763_CR33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tig.2021.06.014","volume":"38","author":"RL Kan","year":"2022","unstructured":"Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2022;38:182\u201393.","journal-title":"Trends Genet"},{"key":"763_CR34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.gendis.2018.06.003","volume":"5","author":"M Fardi","year":"2018","unstructured":"Fardi M, Solali S, Farshdousti Hagh M. Epigenetic mechanisms as a new approach in cancer treatment: an updated review. Genes Dis. 2018;5:304\u201311.","journal-title":"Genes Dis"},{"key":"763_CR35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41588-020-0618-1","volume":"52","author":"D Douillet","year":"2020","unstructured":"Douillet D, Sze CC, Ryan C, Piunti A, Shah AP, Ugarenko M, et al. Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, polycomb and DNA methylation. Nat Genet. 2020;52:615\u201325.","journal-title":"Nat Genet"},{"key":"763_CR36","doi-asserted-by":"crossref","unstructured":"Zhang B, Gu X, Han X, Gao Q, Liu J, Guo T, et al. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells. Clin Epigenetics. 2020;12.","DOI":"10.1186\/s13148-020-00835-3"},{"key":"763_CR37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes AR, Scheyltjens I, Lodi F, Messiaen J, Antoranz A, Duerinck J, et al. Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci. 2021;24:595\u2013610.","journal-title":"Nat Neurosci"},{"key":"763_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12061664","volume":"12","author":"FA Verza","year":"2020","unstructured":"Verza FA, Das U, Fachin AL, Dimmock JR, Marins M. Roles of histone deacetylases and inhibitors in anticancer therapy. Cancers (Basel). 2020;12:1\u201328.","journal-title":"Cancers (Basel)"},{"key":"763_CR39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2016.12.001","volume":"795","author":"RK Khangura","year":"2017","unstructured":"Khangura RK, Bali A, Jaggi AS, Singh N. Histone acetylation and histone deacetylation in neuropathic pain: an unresolved puzzle? Eur J Pharmacol. 2017;795:36\u201342.","journal-title":"Eur J Pharmacol"},{"key":"763_CR40","doi-asserted-by":"crossref","unstructured":"Kabir F, Atkinson R, Cook AL, Phipps AJ, King AE. The role of altered protein acetylation in neurodegenerative disease. Front Aging Neurosci. 2023;14.","DOI":"10.3389\/fnagi.2022.1025473"},{"key":"763_CR41","doi-asserted-by":"crossref","unstructured":"Pereira M, Cruz MT, Fortuna A, Bicker J. Restoring the epigenome in alzheimer\u2019s disease: advancing HDAC inhibitors as therapeutic agents. Drug Discov Today. 2024;29.","DOI":"10.1016\/j.drudis.2024.104052"},{"key":"763_CR42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jnc.14309","volume":"145","author":"EA Thomas","year":"2018","unstructured":"Thomas EA, D\u2019Mello SR. Complex neuroprotective and neurotoxic effects of histone deacetylases. J Neurochem. 2018;145:96\u2013110.","journal-title":"J Neurochem"},{"key":"763_CR43","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10571-020-00994-0","volume":"42","author":"A Srivastava","year":"2022","unstructured":"Srivastava A, Banerjee J, Dubey V, Tripathi M, Chandra PS, Sharma MC, et al. Role of altered Expression, activity and Sub-cellular distribution of various histone deacetylases (HDACs) in mesial Temporal lobe epilepsy with hippocampal sclerosis. Cell Mol Neurobiol. 2022;42:1049\u201364.","journal-title":"Cell Mol Neurobiol"},{"key":"763_CR44","doi-asserted-by":"crossref","unstructured":"Wang J, Yun F, Sui J, Liang W, Shen D, Zhang Q. HAT- and HDAC-targeted protein acetylation in the occurrence and treatment of epilepsy. Biomedicines 2022;11.","DOI":"10.3390\/biomedicines11010088"},{"key":"763_CR45","doi-asserted-by":"crossref","unstructured":"Niu Z, Chen C, Wang S, Lu C, Wu Z, Wang A, et al. HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription. Nat Commun. 2024;15.","DOI":"10.1038\/s41467-024-47900-6"},{"key":"763_CR46","doi-asserted-by":"crossref","unstructured":"Zhang LY, Zhang SY, Wen R, Zhang TN, Yang N. Role of histone deacetylases and their inhibitors in neurological diseases. Pharmacol Res. 2024;208.","DOI":"10.1016\/j.phrs.2024.107410"},{"key":"763_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbrc.2023.09.023","volume":"680","author":"Y Deng","year":"2023","unstructured":"Deng Y, Cheng Q, He J. HDAC inhibitors: promising agents for leukemia treatment. Biochem Biophys Res Commun. 2023;680:61\u201372.","journal-title":"Biochem Biophys Res Commun"},{"key":"763_CR48","first-page":"329","volume":"23","author":"A Mullard","year":"2024","unstructured":"Mullard A. FDA approves an HDAC inhibitor for Duchenne muscular dystrophy. Nat Rev Drug Discov. 2024;23:329.","journal-title":"Nat Rev Drug Discov"},{"key":"763_CR49","doi-asserted-by":"crossref","unstructured":"He X, Hui Z, Xu L, Bai R, Gao Y, Wang Z, et al. Medicinal chemistry updates of novel HDACs inhibitors (2020 to present). Eur J Med Chem. 2022;227.","DOI":"10.1016\/j.ejmech.2021.113946"},{"key":"763_CR50","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/med.21437","volume":"37","author":"C Zagni","year":"2017","unstructured":"Zagni C, Floresta G, Monciino G, Rescifina A. The search for Potent, Small-Molecule HDACIs in cancer treatment: A decade after Vorinostat. Med Res Rev. 2017;37:1373\u2013428.","journal-title":"Med Res Rev"},{"key":"763_CR51","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1039\/C9RA02985K","volume":"9","author":"F Yang","year":"2019","unstructured":"Yang F, Zhao N, Ge D, Chen Y. Next-generation of selective histone deacetylase inhibitors. RSC Adv. 2019;9:19571\u201383.","journal-title":"RSC Adv"},{"key":"763_CR52","doi-asserted-by":"crossref","unstructured":"Hontecillas-Prieto L, Flores-Campos R, Silver A, de \u00c1lava E, Hajji N, Garc\u00eda-Dom\u00ednguez DJ. Synergistic enhancement of cancer therapy using HDAC inhibitors: opportunity for clinical trials. Front Genet. 2020;11.","DOI":"10.3389\/fgene.2020.578011"},{"key":"763_CR53","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbadis.2015.10.010","volume":"1862","author":"CD Troletti","year":"2016","unstructured":"Troletti CD, de Goede P, Kamermans A, de Vries HE. Molecular alterations of the blood-brain barrier under inflammatory conditions: the role of endothelial to mesenchymal transition. Biochim Biophys Acta Mol Basis Dis. 2016;1862:452\u201360.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"763_CR54","doi-asserted-by":"crossref","unstructured":"Sadanandan J, Thomas S, Mathew IE, Huang Z, Blackburn SL, Tandon N, et al. Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrier. elife. 2024;12.","DOI":"10.7554\/eLife.86978.3"},{"key":"763_CR55","doi-asserted-by":"crossref","unstructured":"Fang Z, Sun X, Wang X, Ma J, Palaia T, Rana U, et al. NOGOB receptor deficiency increases cerebrovascular permeability and hemorrhage via impairing histone acetylation-mediated CCM1\/2 expression. J Clin Invest. 2022;132.","DOI":"10.1172\/JCI151382"},{"key":"763_CR56","doi-asserted-by":"crossref","unstructured":"Lisowska J, R\u00f6del CJ, Manet S, Miroshnikova YA, Boyault C, Planus E, et al. The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity. J Cell Sci. 2018;131.","DOI":"10.1242\/jcs.216093"},{"key":"763_CR57","doi-asserted-by":"crossref","unstructured":"Hansen CE, Hollaus D, Kamermans A, de Vries HE. Tension at the gate: sensing mechanical forces at the blood-brain barrier in health and disease. J Neuroinflammation. 2024;21.","DOI":"10.1186\/s12974-024-03321-2"},{"key":"763_CR58","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbamem.2007.08.018","volume":"1778","author":"L Gonz\u00e1lez-Mariscal","year":"2008","unstructured":"Gonz\u00e1lez-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta Biomembr. 2008;1778:729\u201356.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"763_CR59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jnc.14619","volume":"149","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Yu Z, Zhang F, Huang L, Xing C, Liu N, et al. HDAC3 Inhibition prevents oxygen glucose deprivation\/reoxygenation-induced transendothelial permeability by elevating PPAR\u03b3 activity in vitro. J Neurochem. 2019;149:298\u2013310.","journal-title":"J Neurochem"},{"key":"763_CR60","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/jcmm.12803","volume":"20","author":"W Shi","year":"2016","unstructured":"Shi W, Wei X, Wang Z, Han H, Fu Y, Liu J, et al. HDAC9 exacerbates endothelial injury in cerebral ischaemia\/reperfusion injury. J Cell Mol Med. 2016;20:1139\u201349.","journal-title":"J Cell Mol Med"},{"key":"763_CR61","doi-asserted-by":"crossref","unstructured":"Zhang QY, Wang ZJ, Sun DM, Wang Y, Xu P, Wu WJ, et al. Novel therapeutic effects of leonurine on ischemic stroke: new mechanisms of BBB integrity. Oxid Med Cell Longev. 2017;2017.","DOI":"10.1155\/2017\/7150376"},{"key":"763_CR62","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.2147\/JIR.S416239","volume":"16","author":"HK Wang","year":"2023","unstructured":"Wang HK, Su YT, Ho YC, Lee YK, Chu TH, Chen KT, et al. HDAC1 is involved in neuroinflammation and Blood-Brain barrier damage in stroke pathogenesis. J Inflamm Res. 2023;16:4103\u201316.","journal-title":"J Inflamm Res"},{"key":"763_CR63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/gerona\/gly167","volume":"74","author":"S Kim","year":"2019","unstructured":"Kim S, Bin, Heo JI, Kim H, Kim KS. Acetylation of PGC1\u03b1 by histone deacetylase 1 downregulation is implicated in Radiation-Induced senescence of brain endothelial cells. J Gerontol Biol Sci Med Sci. 2019;74:787\u201393.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"763_CR64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243\u201378.","journal-title":"Cell"},{"key":"763_CR65","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","volume":"176","author":"JM Perez Ortiz","year":"2019","unstructured":"Perez Ortiz JM, Swerdlow RH. Mitochondrial dysfunction in alzheimer\u2019s disease: role in pathogenesis and novel therapeutic opportunities. Br J Pharmacol. 2019;176:3489\u2013507.","journal-title":"Br J Pharmacol"},{"key":"763_CR66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cmet.2006.04.013","volume":"3","author":"C Lerin","year":"2006","unstructured":"Lerin C, Rodgers JT, Kalume DE, Kim S, hee, Pandey A, Puigserver P. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1\u03b1. Cell Metab. 2006;3:429\u201338.","journal-title":"Cell Metab"},{"key":"763_CR67","doi-asserted-by":"crossref","first-page":"1452696","DOI":"10.1155\/2020\/1452696","volume":"2020","author":"S Rius-P\u00e9rez","year":"2020","unstructured":"Rius-P\u00e9rez S, Torres-Cuevas I, Mill\u00e1n I, Ortega \u00c1L, P\u00e9rez S, Sandhu MA. PGC-1\u03b1, Inflammation, and oxidative stress: an integrative view in metabolism. Oxid Med Cell Longev. 2020;2020:1452696.","journal-title":"Oxid Med Cell Longev"},{"key":"763_CR68","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","volume":"27","author":"C Handschin","year":"2006","unstructured":"Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006;27:728\u201335.","journal-title":"Endocr Rev"},{"key":"763_CR69","first-page":"1","volume":"22","author":"Z Sun","year":"2025","unstructured":"Sun Z, Sun Z, Zhao Y, Zhang L, Xie F, Wang X, et al. Rutin ameliorates stress\u2013induced blood\u2013brain barrier dysfunction and cognitive decline via the endothelial HDAC1\u2013Claudin\u20135 axis. Fluids Barriers CNS. 2025;22:1\u201318.","journal-title":"Fluids Barriers CNS"},{"key":"763_CR70","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1007\/s12035-019-1565-7","volume":"56","author":"D You","year":"2019","unstructured":"You D, Wen X, Gorczyca L, Morris A, Richardson JR, Aleksunes LM. Increased MDR1 transporter expression in human brain endothelial cells through enhanced histone acetylation and activation of Aryl hydrocarbon receptor signaling. Mol Neurobiol. 2019;56:6986\u20137002.","journal-title":"Mol Neurobiol"},{"key":"763_CR71","doi-asserted-by":"crossref","unstructured":"Inoue Y, Ren Y, Zhang S, Bamkole M, Islam NN, Selvaraj M, et al. A novel histone deacetylase inhibitor W2A-16 improves the barrier integrity in brain vascular endothelial cells. Front Cell Neurosci. 2024;18.","DOI":"10.3389\/fncel.2024.1368018"},{"key":"763_CR72","doi-asserted-by":"crossref","unstructured":"Zhao Q, Zhang F, Yu Z, Guo S, Liu N, Jiang Y, et al. HDAC3 Inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice. J Neuroinflammation. 2019;16.","DOI":"10.1186\/s12974-019-1495-3"},{"key":"763_CR73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/1673-5374.265562","volume":"15","author":"L Su","year":"2020","unstructured":"Su L, Liang D, Kuang SY, Dong Q, Han X, Wang Z. Neuroprotective mechanism of TMP269, a selective class IIA histone deacetylase inhibitor, after cerebral ischemia\/reperfusion injury. Neural Regen Res. 2020;15:277\u201384.","journal-title":"Neural Regen Res"},{"key":"763_CR74","doi-asserted-by":"crossref","unstructured":"Zhao M, Jiang XF, Zhang HQ, Sun JH, Pei H, Ma LN, et al. Interactions between glial cells and the blood-brain barrier and their role in Alzheimer\u2019s disease. Ageing Res Rev. 2021;72.","DOI":"10.1016\/j.arr.2021.101483"},{"key":"763_CR75","doi-asserted-by":"crossref","unstructured":"Sierra A, Miron VE, Paolicelli RC, Ransohoff RM. Microglia in health and diseases: integrative hubs of the central nervous system (CNS). Cold Spring Harb Perspect Biol. 2024;16.","DOI":"10.1101\/cshperspect.a041366"},{"key":"763_CR76","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","volume":"54","author":"K Borst","year":"2021","unstructured":"Borst K, Dumas AA, Prinz M, Microglia. Immune and non-immune functions. Immunity. 2021;54:2194\u2013208.","journal-title":"Immunity"},{"key":"763_CR77","doi-asserted-by":"crossref","unstructured":"Qin J, Ma Z, Chen X, Shu S. Microglia activation in central nervous system disorders: a review of recent mechanistic investigations and development efforts. Front Neurol. 2023;14.","DOI":"10.3389\/fneur.2023.1103416"},{"key":"763_CR78","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/pharmaceutics14071420","volume":"14","author":"F Cavalcanti","year":"2022","unstructured":"Cavalcanti F, Gonzalez-Rey E, Delgado M, Falo CP, Mestre L, Guaza C, et al. Efficacy of vafidemstat in experimental autoimmune Encepha-Lomyelitis highlights the KDM1A\/RCOR1\/HDAC epigenetic axis in multiple sclerosis. Pharmaceutics. 2022;14:1420.","journal-title":"Pharmaceutics"},{"key":"763_CR79","first-page":"1","volume":"22","author":"A Dey","year":"2025","unstructured":"Dey A, Butcher M, Gegonne A, Yagi R, Saeki K, Lee E, et al. Brd4 expression in CD4 T cells and in microglia promotes neuroinflammation in experimental autoimmune encephalomyelitis. J Neuroinflamm. 2025;22:1\u201315.","journal-title":"J Neuroinflamm"},{"key":"763_CR80","doi-asserted-by":"crossref","unstructured":"Cho DY, Han JH, Kim IS, Lim JH, Ko HM, Kim B, et al. The acetyltransferase GCN5 contributes to neuroinflammation in mice by acetylating and activating the NF-\u03baB subunit p65 in microglia. Sci Signal. 2025;18.","DOI":"10.1126\/scisignal.adp8973"},{"key":"763_CR81","doi-asserted-by":"crossref","unstructured":"Kuboyama T, Wahane S, Huang Y, Zhou X, Wong JK, Koemeter-Cox A, et al. HDAC3 inhibition ameliorates spinal cord injury by immunomodulation. Sci Rep. 2017;7.","DOI":"10.1038\/s41598-017-08535-4"},{"key":"763_CR82","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1096\/fj.201900394RRR","volume":"34","author":"MJ Zhang","year":"2020","unstructured":"Zhang MJ, Zhao QC, Xia MX, Chen J, Chen YT, Cao X, et al. The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome. FASEB J. 2020;34:648\u201362.","journal-title":"FASEB J"},{"key":"763_CR83","doi-asserted-by":"crossref","unstructured":"Zhao Y, Mu H, Huang Y, Li S, Wang Y, Stetler RA, et al. Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury. J Neuroinflammation. 2022;19.","DOI":"10.1186\/s12974-022-02563-2"},{"key":"763_CR84","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7150\/thno.103449","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Wang C, Zhang Y, Huang Y, Shi Z, Zhang Y, et al. Orchestrating the frontline: HDAC3-miKO recruits macrophage reinforcements for accelerated Myelin debris clearance after stroke. Theranostics. 2025;15:632\u201355.","journal-title":"Theranostics"},{"key":"763_CR85","doi-asserted-by":"crossref","unstructured":"Meleady L, Towriss M, Kim J, Bacarac V, Dang V, Rowland ME, et al. Histone deacetylase 3 regulates microglial function through histone deacetylation. Epigenetics. 2023;18.","DOI":"10.1080\/15592294.2023.2241008"},{"key":"763_CR86","doi-asserted-by":"crossref","unstructured":"Huang M, Malovic E, Ealy A, Jin H, Anantharam V, Kanthasamy A, et al. Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1052925"},{"key":"763_CR87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12974-014-0141-3","volume":"11","author":"C Quintas","year":"2014","unstructured":"Quintas C, Pinho D, Pereira C, Saraiva L, Gon\u00e7alves J, Queiroz G. Microglia P2Y6 receptors mediate nitric oxide release and astrocyte apoptosis. J Neuroinflammation. 2014;11:141.","journal-title":"J Neuroinflammation"},{"key":"763_CR88","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.freeradbiomed.2020.11.005","volume":"162","author":"A Ledo","year":"2021","unstructured":"Ledo A, Louren\u00e7o CF, Cadenas E, Barbosa RM, Laranjinha J. The bioactivity of neuronal-derived nitric oxide in aging and neurodegeneration: switching signaling to degeneration. Free Radic Biol Med. 2021;162:500\u201313.","journal-title":"Free Radic Biol Med"},{"key":"763_CR89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroscience.2017.12.039","volume":"405","author":"MJ Haley","year":"2019","unstructured":"Haley MJ, Brough D, Quintin J, Allan SM. Microglial priming as trained immunity in the brain. Neuroscience. 2019;405:47\u201354.","journal-title":"Neuroscience"},{"key":"763_CR90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/ATVBAHA.120.314212","volume":"41","author":"H Tercan","year":"2021","unstructured":"Tercan H, Riksen NP, Joosten LAB, Netea MG, Bekkering S. Trained immunity: Long-Term adaptation in innate immune responses. Arterioscler Thromb Vasc Biol. 2021;41:55\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"763_CR91","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12079-021-00663-x","volume":"16","author":"AFO Justo","year":"2022","unstructured":"Justo AFO, Suemoto CK. The modulation of neuroinflammation by inducible nitric oxide synthase. J Cell Commun Signal. 2022;16:155\u20138.","journal-title":"J Cell Commun Signal"},{"key":"763_CR92","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev-cellbio-100617-062608","volume":"35","author":"UH Langen","year":"2019","unstructured":"Langen UH, Ayloo S, Gu C. Development and cell biology of the Blood-Brain barrier. Annu Rev Cell Dev Biol. 2019;35:591.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"763_CR93","doi-asserted-by":"crossref","unstructured":"Schiera G, Di Liegro CM, Schir\u00f2 G, Sorbello G, Di Liegro I. Involvement of astrocytes in the formation, maintenance, and function of the blood-brain barrier. Cells. 2024;13.","DOI":"10.3390\/cells13020150"},{"key":"763_CR94","doi-asserted-by":"crossref","unstructured":"Manu DR, Slevin M, Barcutean L, Forro T, Boghitoiu T, Balasa R. Astrocyte involvement in blood-brain barrier function: a critical update highlighting novel, complex, neurovascular interactions. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms242417146"},{"key":"763_CR95","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12035-022-03083-z","volume":"60","author":"H Lu","year":"2023","unstructured":"Lu H, Ashiqueali R, Lin CI, Walchale A, Clendaniel V, Matheson R, et al. Histone deacetylase 3 Inhibition decreases cerebral edema and protects the Blood-Brain barrier after stroke. Mol Neurobiol. 2023;60:235\u201346.","journal-title":"Mol Neurobiol"},{"key":"763_CR96","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.1007\/s12035-016-0185-8","volume":"54","author":"S Liu","year":"2017","unstructured":"Liu S, Mao J, Wang T, Fu X. Downregulation of Aquaporin-4 protects brain against hypoxia ischemia via Anti-inflammatory mechanism. Mol Neurobiol. 2017;54:6426\u201335.","journal-title":"Mol Neurobiol"},{"key":"763_CR97","doi-asserted-by":"crossref","unstructured":"Lituma PJ, Woo E, O\u2019Hara BF, Castillo PE, Sibinga NES, Nandi S. Altered synaptic connectivity and brain function in mice lacking microglial adapter protein Iba1. Proc Natl Acad Sci USA. 2021;118.","DOI":"10.1073\/pnas.2115539118"},{"key":"763_CR98","doi-asserted-by":"crossref","unstructured":"Jia H, Wang Y, Morris CD, Jacques V, Gottesfeld JM, Rusche JR et al. The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington\u2019s disease mice. PLoS ONE 2016;11.","DOI":"10.1371\/journal.pone.0152498"},{"key":"763_CR99","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1038\/s41598-017-05125-2","volume":"7","author":"N Suelves","year":"2017","unstructured":"Suelves N, Kirkham-McCarthy L, Lahue RS, Gin\u00e9s S. A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in huntington\u2019s disease mice. Sci Rep. 2017;7:6082.","journal-title":"Sci Rep"},{"key":"763_CR100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41593-024-01580-z","volume":"27","author":"BLL Clayton","year":"2024","unstructured":"Clayton BLL, Kristell JD, Allan KC, Cohn EF, Karl M, Jerome AD, et al. A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity. Nat Neurosci. 2024;27:656\u201365.","journal-title":"Nat Neurosci"},{"key":"763_CR101","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1523\/JNEUROSCI.1604-18.2018","volume":"39","author":"GC Sartor","year":"2019","unstructured":"Sartor GC, Malvezzi AM, Kumar A, Andrade NS, Wiedner HJ, Vilca SJ, et al. Enhancement of BDNF expression and memory by HDAC Inhibition requires BET bromodomain reader proteins. J Neurosci. 2019;39:612\u201326.","journal-title":"J Neurosci"},{"key":"763_CR102","doi-asserted-by":"crossref","unstructured":"Villarreal A, Vidos C, Monteverde Busso M, Cieri MB, Ramos AJ. Pathological neuroinflammatory conversion of reactive astrocytes is induced by microglia and involves chromatin remodeling. Front Pharmacol. 2021;12.","DOI":"10.3389\/fphar.2021.689346"},{"key":"763_CR103","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1097-2765(02)00477-X","volume":"9","author":"H Zhong","year":"2002","unstructured":"Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-\u03baB determines its association with CBP\/p300 or HDAC-1. Mol Cell. 2002;9:625\u201336.","journal-title":"Mol Cell"},{"key":"763_CR104","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tibs.2008.04.015","volume":"33","author":"M Calao","year":"2008","unstructured":"Calao M, Burny A, Quivy V, Dekoninck A, Van Lint C. A pervasive role of histone acetyltransferases and deacetylases in an NF-\u03baB-signaling code. Trends Biochem Sci. 2008;33:339\u201349.","journal-title":"Trends Biochem Sci"},{"key":"763_CR105","doi-asserted-by":"crossref","unstructured":"Mukherjee SP, Behar M, Birnbaum HA, Hoffmann A, Wright PE, Ghosh G. Analysis of the RelA:CBP\/p300 interaction reveals its involvement in NF-\u03baB-driven transcription. PLoS Biol. 2013;11.","DOI":"10.1371\/journal.pbio.1001647"},{"key":"763_CR106","doi-asserted-by":"crossref","first-page":"32091","DOI":"10.1074\/jbc.274.45.32091","volume":"274","author":"W Berghe","year":"1999","unstructured":"Berghe W, De Vanden K, Boone E, Plaisance S, Haegeman G. The nuclear factor-\u03baB engages CBP\/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem. 1999;274:32091\u20138.","journal-title":"J Biol Chem"},{"key":"763_CR107","doi-asserted-by":"crossref","unstructured":"Pao PC, Patnaik D, Watson LA, Gao F, Pan L, Wang J, et al. HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer\u2019s disease. Nat Commun. 2020;11.","DOI":"10.1038\/s41467-020-16361-y"},{"key":"763_CR108","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/stem.1977","volume":"33","author":"T Nakagomi","year":"2015","unstructured":"Nakagomi T, Kubo S, Nakano-Doi A, Sakuma R, Lu S, Narita A, et al. Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells. Stem Cells. 2015;33:1962\u201374.","journal-title":"Stem Cells"},{"key":"763_CR109","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.7150\/thno.97165","volume":"14","author":"A Loan","year":"2024","unstructured":"Loan A, Awaja N, Lui M, Syal C, Sun Y, Sarma SN, et al. Single-cell profiling of brain pericyte heterogeneity following ischemic stroke unveils distinct pericyte subtype-targeted neural reprogramming potential and its underlying mechanisms. Theranostics. 2024;14:6110\u201337.","journal-title":"Theranostics"},{"key":"763_CR110","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/STROKEAHA.123.045248","volume":"55","author":"JM Dave","year":"2024","unstructured":"Dave JM, Chakraborty R, Agyemang A, Ntokou A, Saito J, Ballabh P, et al. Loss of TGF\u03b2-Mediated repression of Angiopoietin-2 in pericytes underlies germinal matrix hemorrhage pathogenesis. Stroke. 2024;55:2340\u201352.","journal-title":"Stroke"},{"key":"763_CR111","first-page":"1","volume":"15","author":"Q Ge","year":"2025","unstructured":"Ge Q, Guo J, Ye L, Le Y, Zhu J. PKM2 regulates angiogenic activation via ANGPT2 in endothelial cells. Sci Rep. 2025;15:1\u201311.","journal-title":"Sci Rep"},{"key":"763_CR112","first-page":"1","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, Kim MJ, Kumar A, Lee HW, Yang Y, Kim Y. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther. 2025;10:1\u201340.","journal-title":"Signal Transduct Target Ther"},{"key":"763_CR113","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41556-020-0526-8","volume":"22","author":"BN Sheikh","year":"2020","unstructured":"Sheikh BN, Guhathakurta S, Tsang TH, Schwabenland M, Renschler G, Herquel B, et al. Neural metabolic imbalance induced by MOF dysfunction triggers pericyte activation and breakdown of vasculature. Nat Cell Biol. 2020;22:828\u201341.","journal-title":"Nat Cell Biol"},{"key":"763_CR114","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1021\/acschemneuro.4c00124","volume":"15","author":"AK Singh","year":"2024","unstructured":"Singh AK, Rai A, Joshi I, Reddy DN, Guha R, Alka K, et al. Oral administration of a specific p300\/CBP lysine acetyltransferase activator induces synaptic plasticity and repairs spinal cord injury. ACS Chem Neurosci. 2024;15:2741\u201355.","journal-title":"ACS Chem Neurosci"},{"key":"763_CR115","doi-asserted-by":"crossref","unstructured":"Hutson TH, Kathe C, Palmisano I, Bartholdi K, Hervera A, De Virgiliis F, et al. Cbp-dependent histone acetylation mediates axon regeneration induced by environmental enrichment in rodent spinal cord injury models. Sci Transl Med. 2019;11.","DOI":"10.1126\/scitranslmed.aaw2064"},{"key":"763_CR116","doi-asserted-by":"crossref","unstructured":"M\u00fcller F, De Virgiliis F, Kong G, Zhou L, Serger E, Chadwick J, et al. CBP\/p300 activation promotes axon growth, sprouting, and synaptic plasticity in chronic experimental spinal cord injury with severe disability. PLoS Biol. 2022;20.","DOI":"10.1371\/journal.pbio.3001310"},{"key":"763_CR117","doi-asserted-by":"crossref","unstructured":"Paiva I, Seguin J, Grgurina I, Singh AK, Cosquer B, Plassard D, et al. Dysregulated expression of cholesterol biosynthetic genes in Alzheimer\u2019s disease alters epigenomic signatures of hippocampal neurons. Neurobiol Dis. 2024;198.","DOI":"10.1016\/j.nbd.2024.106538"},{"key":"763_CR118","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1523\/JNEUROSCI.5772-12.2013","volume":"33","author":"S Chatterjee","year":"2013","unstructured":"Chatterjee S, Mizar P, Cassel R, Neidl R, Ruthrotha Selvi B, Mohankrishna DV, et al. A novel activator of CBP\/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice. J Neurosci. 2013;33:10698\u2013712.","journal-title":"J Neurosci"},{"key":"763_CR119","doi-asserted-by":"crossref","unstructured":"Chatterjee S, Cassel R, Schneider-Anthony A, Merienne K, Cosquer B, Tzeplaeff L, et al. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Mol Med. 2018;10.","DOI":"10.15252\/emmm.201708587"},{"key":"763_CR120","doi-asserted-by":"crossref","unstructured":"Singh AK, Neo SH, Liwang C, Pang KKL, Leng JCK, Sinha SH, et al. Glucose derived carbon nanosphere (CSP) conjugated TTK21, an activator of the histone acetyltransferases CBP\/p300, ameliorates amyloid-beta 1\u201342 induced deficits in plasticity and associativity in hippocampal CA1 pyramidal neurons. Aging Cell. 2022;21.","DOI":"10.1111\/acel.13675"},{"key":"763_CR121","first-page":"3","volume":"30","author":"SV Hegarty","year":"2016","unstructured":"Hegarty SV, O\u2019Leary E, Solger F, Stanicka J, Sullivan AM, O\u2019Keeffe GW. A small molecule activator of p300\/CBP histone acetyltransferase promotes survival and neurite growth in a cellular model of parkinson\u2019s disease. Neurotox Res 2016. 2016;30:3.","journal-title":"Neurotox Res 2016"},{"key":"763_CR122","doi-asserted-by":"crossref","unstructured":"Nakayama T, Singh AK, Fukutomi T, Uchida N, Terao Y, Hamada H, et al. Activator of KAT3 histone acetyltransferase family ameliorates a neurodevelopmental disorder phenotype in the syntaxin 1A ablated mouse model. Cell Rep. 2024;43.","DOI":"10.1016\/j.celrep.2024.114101"},{"key":"763_CR123","doi-asserted-by":"crossref","unstructured":"Singh AK, Joshi I, Reddy NMN, Purushotham SS, Eswaramoorthy M, Vasudevan M, et al. Epigenetic modulation rescues neurodevelopmental deficits in Syngap1+\/- mice. Aging Cell. 2025;24.","DOI":"10.1111\/acel.14408"},{"key":"763_CR124","doi-asserted-by":"crossref","unstructured":"Bian HT, Xiao L, Liang L, Xie YP, Wang HL, Wang GH. RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation. Int Immunopharmacol. 2021;101.","DOI":"10.1016\/j.intimp.2021.108259"},{"key":"763_CR125","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.devcel.2010.08.012","volume":"19","author":"CM Trivedi","year":"2010","unstructured":"Trivedi CM, Zhu W, Wang Q, Jia C, Kee HJ, Li L, et al. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev Cell. 2010;19:450.","journal-title":"Dev Cell"},{"key":"763_CR126","doi-asserted-by":"crossref","first-page":"13716","DOI":"10.1074\/jbc.M609751200","volume":"282","author":"H Higashitsuji","year":"2007","unstructured":"Higashitsuji H, Higashitsuji H, Masuda T, Liu Y, Itoh K, Fujita J. Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. J Biol Chem. 2007;282:13716\u201325.","journal-title":"J Biol Chem"},{"key":"763_CR127","doi-asserted-by":"crossref","unstructured":"Shen Y, Yang R, Zhao J, Chen M, Chen S, Ji B, et al. The histone deacetylase inhibitor Belinostat ameliorates experimental autoimmune encephalomyelitis in mice by inhibiting TLR2\/MyD88 and HDAC3\/ NF-\u03baB p65-mediated neuroinflammation. Pharmacol Res. 2022;176.","DOI":"10.1016\/j.phrs.2021.105969"},{"key":"763_CR128","doi-asserted-by":"crossref","unstructured":"Chen S, Ye J, Chen X, Shi J, Wu W, Lin W, et al. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3. J Neuroinflammation. 2018;15.","DOI":"10.1186\/s12974-018-1193-6"},{"key":"763_CR129","doi-asserted-by":"crossref","unstructured":"Sivandzade F, Cucullo L. Anti-diabetic countermeasures against tobacco smoke-dependent cerebrovascular toxicity: use and effect of rosiglitazone. Int J Mol Sci. 2019;20.","DOI":"10.1186\/s12868-019-0497-5"},{"key":"763_CR130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2020.01.118","volume":"524","author":"K Ogawa","year":"2020","unstructured":"Ogawa K, Yagi T, Guo T, Takeda K, Ohguchi H, Koyama H, et al. Pemafibrate, a selective PPAR\u03b1 modulator, and Fenofibrate suppress microglial activation through distinct PPAR\u03b1 and SIRT1-dependent pathways. Biochem Biophys Res Commun. 2020;524:385\u201391.","journal-title":"Biochem Biophys Res Commun"},{"key":"763_CR131","first-page":"3","volume":"31","author":"P Thangwong","year":"2023","unstructured":"Thangwong P, Jearjaroen P, Tocharus C, Govitrapong P, Tocharus J. Melatonin suppresses inflammation and blood\u2013brain barrier disruption in rats with vascular dementia possibly by activating the SIRT1\/PGC-1\u03b1\/PPAR\u03b3 signaling pathway. Inflammopharmacology 2023. 2023;31:3.","journal-title":"Inflammopharmacology 2023"},{"key":"763_CR132","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","volume":"321","author":"JK Hyeon","year":"2007","unstructured":"Hyeon JK, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther. 2007;321:892\u2013901.","journal-title":"J Pharmacol Exp Ther"},{"key":"763_CR133","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1096\/fj.09-134700","volume":"23","author":"NA Shein","year":"2009","unstructured":"Shein NA, Grigoriadis N, Alexandrovich AG, Simeonidou C, Lourbopoulos A, Polyzoidou E, et al. Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J. 2009;23:4266\u201375.","journal-title":"FASEB J"},{"key":"763_CR134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2013.07.007","volume":"263","author":"S Kalinin","year":"2013","unstructured":"Kalinin S, Polak PE, Lin SX, Braun D, Guizzetti M, Zhang X, et al. Dimethyl fumarate regulates histone deacetylase expression in astrocytes. J Neuroimmunol. 2013;263:13\u20139.","journal-title":"J Neuroimmunol"},{"key":"763_CR135","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1200\/JCO.2005.02.188","volume":"23","author":"QC Ryan","year":"2005","unstructured":"Ryan QC, Headlee D, Acharya M, Sparreboom A, Trepel JB, Ye J, et al. Phase I and Pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. J Clin Oncol. 2005;23:3912\u201322.","journal-title":"J Clin Oncol"},{"key":"763_CR136","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2119\/molmed.2011.00020","volume":"17","author":"A Furlan","year":"2011","unstructured":"Furlan A, Monzani V, Reznikov LL, Leoni F, Fossati G, Modena D, et al. Pharmacokinetics, safety and inducible cytokine responses during a phase 1 trial of the oral histone deacetylase inhibitor ITF2357 (givinostat). Mol Med. 2011;17:353\u201362.","journal-title":"Mol Med"},{"key":"763_CR137","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/neuonc\/nor017","volume":"13","author":"FM Iwamoto","year":"2011","unstructured":"Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Alfred Yung WK, Gilbert MR, et al. A phase I\/II trial of the histone deacetylase inhibitor Romidepsin for adults with recurrent malignant glioma: North American brain tumor consortium study 03\u201303. Neuro Oncol. 2011;13:509.","journal-title":"Neuro Oncol"},{"key":"763_CR138","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1158\/1078-0432.CCR-07-0162","volume":"13","author":"SS Ramalingam","year":"2007","unstructured":"Ramalingam SS, Parise RA, Ramananthan RK, Lagattuta TF, Musguire LA, Stoller RG, et al. Phase I and Pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and Paclitaxel for advanced solid malignancies. Clin Cancer Res. 2007;13:3605\u201310.","journal-title":"Clin Cancer Res"},{"key":"763_CR139","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/00498254.2016.1184356","volume":"47","author":"NR Srinivas","year":"2017","unstructured":"Srinivas NR. Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives. Xenobiotica. 2017;47:354\u201368.","journal-title":"Xenobiotica"},{"key":"763_CR140","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1111\/bcp.14889","volume":"87","author":"AD Bondarev","year":"2021","unstructured":"Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schi\u00f6th HB. Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol. 2021;87:4577\u201397.","journal-title":"Br J Clin Pharmacol"},{"key":"763_CR141","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00280-007-0622-5","volume":"62","author":"KE Warren","year":"2008","unstructured":"Warren KE, McCully C, Dvinge H, Tj\u00f8rnelund J, Sehested M, Lichenstein HS, et al. Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, Belinostat (PXD101), in non-human primates. Cancer Chemother Pharmacol. 2008;62:433\u20137.","journal-title":"Cancer Chemother Pharmacol"},{"key":"763_CR142","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00280-019-04021-y","volume":"85","author":"LT Rodgers","year":"2020","unstructured":"Rodgers LT, Lester McCully CM, Odabas A, Cruz R, Peer CJ, Figg WD, et al. Characterizing the pharmacokinetics of Panobinostat in a non-human primate model for the treatment of diffuse intrinsic Pontine glioma. Cancer Chemother Pharmacol. 2020;85:827\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"key":"763_CR143","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1021\/cn9000268","volume":"1","author":"JM Hooker","year":"2010","unstructured":"Hooker JM, Kim SW, Alexoff D, Xu Y, Shea C, Reid A, et al. Histone deacetylase inhibitor, MS-275, exhibits poor brain penetration: PK studies of [C]MS-275 using positron emission tomography. ACS Chem Neurosci. 2010;1:65\u201373.","journal-title":"ACS Chem Neurosci"},{"key":"763_CR144","doi-asserted-by":"crossref","unstructured":"Pili R, Salumbides B, Zhao M, Altiok S, Qian D, Zwiebel J, et al. Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours. Br J Cancer. 2012 106:1 2011;106:77\u201384.","DOI":"10.1038\/bjc.2011.527"},{"key":"763_CR145","doi-asserted-by":"crossref","first-page":"e69964","DOI":"10.1371\/journal.pone.0069964","volume":"8","author":"JE Hanson","year":"2013","unstructured":"Hanson JE, La H, Plise E, Chen YH, Ding X, Hanania T, et al. SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. PLoS ONE. 2013;8:e69964.","journal-title":"PLoS ONE"},{"key":"763_CR146","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/dmd.119.089953","volume":"48","author":"D You","year":"2020","unstructured":"You D, Richardson JR, Aleksunes LM. Epigenetic regulation of multidrug resistance protein 1 and breast cancer resistance protein transporters by histone deacetylase Inhibition. Drug Metab Dispos. 2020;48:459\u201380.","journal-title":"Drug Metab Dispos"},{"key":"763_CR147","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161211797440186","volume":"17","author":"S Agarwal","year":"2011","unstructured":"Agarwal S, Hartz MS, Elmquist AF, Bauer W. Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. Curr Pharm Des. 2011;17:2793\u2013802.","journal-title":"Curr Pharm Des"},{"key":"763_CR148","doi-asserted-by":"crossref","unstructured":"Bossennec M, Di Roio A, Caux C, M\u00e9n\u00e9trier-Caux C. MDR1 in immunity: friend or foe? Oncoimmunology 2018;7.","DOI":"10.1080\/2162402X.2018.1499388"},{"key":"763_CR149","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2967\/jnumed.113.130161","volume":"55","author":"AK Deo","year":"2014","unstructured":"Deo AK, Borson S, Link JM, Domino K, Eary JF, Ke B, et al. Activity of P-Glycoprotein, a \u03b2-Amyloid transporter at the Blood-Brain Barrier, is compromised in patients with mild alzheimer disease. J Nucl Med. 2014;55:1106\u201311.","journal-title":"J Nucl Med"},{"key":"763_CR150","doi-asserted-by":"crossref","first-page":"100014","DOI":"10.1124\/jpet.124.002170","volume":"392","author":"W Zhang","year":"2025","unstructured":"Zhang W, Oh JH, Zhang W, Aldrich CC, Sirianni RW, Elmquist WF. Central nervous system distributional kinetics of selected histone deacetylase inhibitors. J Pharmacol Exp Ther. 2025;392:100014.","journal-title":"J Pharmacol Exp Ther"},{"key":"763_CR151","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/138920008783331077","volume":"9","author":"J Lin","year":"2008","unstructured":"Lin J. CSF as a surrogate for assessing CNS exposure: an industrial perspective. Curr Drug Metab. 2008;9:46\u201359.","journal-title":"Curr Drug Metab"},{"key":"763_CR152","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/17425247.2025.2462767","volume":"22","author":"M Hammarlund-Udenaes","year":"2025","unstructured":"Hammarlund-Udenaes M, Loryan I. Assessing central nervous system drug delivery. Expert Opin Drug Deliv. 2025;22:421\u201339.","journal-title":"Expert Opin Drug Deliv"},{"key":"763_CR153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/21541264.2024.2379161","volume":"15","author":"YM Yao","year":"2024","unstructured":"Yao YM, Miodownik I, O\u2019Hagan MP, Jbara M, Afek A. Deciphering the dynamic code: DNA recognition by transcription factors in the ever-changing genome. Transcription. 2024;15:114\u201338.","journal-title":"Transcription"},{"key":"763_CR154","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.freeradbiomed.2016.11.038","volume":"107","author":"A Klungland","year":"2017","unstructured":"Klungland A, Robertson AB. Oxidized C5-methyl cytosine bases in DNA: 5-Hydroxymethylcytosine; 5-formylcytosine; and 5-carboxycytosine. Free Radic Biol Med. 2017;107:62\u20138.","journal-title":"Free Radic Biol Med"},{"key":"763_CR155","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1093\/nar\/gkx718","volume":"45","author":"N Kitsera","year":"2017","unstructured":"Kitsera N, Allgayer J, Parsa E, Geier N, Rossa M, Carell T, et al. Functional impacts of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine at a single hemi-modified CpG dinucleotide in a gene promoter. Nucleic Acids Res. 2017;45:11033\u201342.","journal-title":"Nucleic Acids Res"},{"key":"763_CR156","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1016\/j.cell.2024.08.011","volume":"187","author":"E Parasyraki","year":"2024","unstructured":"Parasyraki E, Mallick M, Hatch V, Vastolo V, Musheev MU, Karaulanov E, et al. 5-Formylcytosine is an activating epigenetic mark for RNA pol III during zygotic reprogramming. Cell. 2024;187:6088\u2013e610318.","journal-title":"Cell"},{"key":"763_CR157","doi-asserted-by":"crossref","unstructured":"Trush VV, Feller C, Li ASM, Allali-Hassani A, Szewczyk MM, Chau I, et al. Enzymatic nucleosome acetylation selectively affects activity of histone methyltransferases in vitro. Biochim Biophys Acta Gene Regul Mech. 2022;1865.","DOI":"10.1016\/j.bbagrm.2022.194845"},{"key":"763_CR158","doi-asserted-by":"crossref","unstructured":"Yang Q, Chen Y, Guo R, Dai Y, Tang L, Zhao Y, et al. Interaction of ncRNA and epigenetic modifications in gastric cancer: focus on histone modification. Front Oncol. 2022;11.","DOI":"10.3389\/fonc.2021.822745"},{"key":"763_CR159","doi-asserted-by":"crossref","unstructured":"Li D, Peng X, Hu Z, Li S, Chen J, Pan W. Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: current progress and novel strategies. Eur J Med Chem. 2024;264.","DOI":"10.1016\/j.ejmech.2023.115982"},{"key":"763_CR160","doi-asserted-by":"crossref","unstructured":"Walport LJ, Hopkinson RJ, Chowdhury R, Schiller R, Ge W, Kawamura A, et al. Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases. Nat Commun. 2016;7.","DOI":"10.1038\/ncomms11974"},{"key":"763_CR161","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-020-00542-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Tramontano A, Pezone A, Migliaccio A. LSD1: more than demethylation of histone lysine residues. Exp Mol Med. 2020;52:1936\u201347.","journal-title":"Exp Mol Med"},{"key":"763_CR162","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10555-017-9715-8","volume":"37","author":"HJ Ferreira","year":"2018","unstructured":"Ferreira HJ, Esteller M. Non-coding RNAs, epigenetics, and cancer: tying it all together. Cancer Metastasis Rev. 2018;37:55\u201373.","journal-title":"Cancer Metastasis Rev"},{"key":"763_CR163","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.omtn.2020.05.023","volume":"21","author":"X Wu","year":"2020","unstructured":"Wu X, Pan Y, Fang Y, Zhang J, Xie M, Yang F, et al. The biogenesis and functions of PiRNAs in human diseases. Mol Ther Nucleic Acids. 2020;21:108\u201320.","journal-title":"Mol Ther Nucleic Acids"},{"key":"763_CR164","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1074\/jbc.M112.426536","volume":"288","author":"GT Corbett","year":"2013","unstructured":"Corbett GT, Roy A, Pahan K. Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response Element-binding protein (CREB): implication for alzheimer disease therapy. J Biol Chem. 2013;288:8299\u2013312.","journal-title":"J Biol Chem"},{"key":"763_CR165","doi-asserted-by":"crossref","first-page":"e38113","DOI":"10.1371\/journal.pone.0038113","volume":"7","author":"A Roy","year":"2012","unstructured":"Roy A, Ghosh A, Jana A, Liu X, Brahmachari S, Gendelman HE, et al. Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of parkinson\u2019s disease. PLoS ONE. 2012;7:e38113.","journal-title":"PLoS ONE"},{"key":"763_CR166","doi-asserted-by":"crossref","first-page":"14466","DOI":"10.1038\/s41598-021-93232-6","volume":"11","author":"D Bae","year":"2021","unstructured":"Bae D, Lee JY, Ha N, Park J, Baek J, Suh D, et al. CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis. Sci Rep. 2021;11:14466.","journal-title":"Sci Rep"},{"key":"763_CR167","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbi.2025.05.027","volume":"129","author":"V Haage","year":"2025","unstructured":"Haage V, Tuddenham JF, Bautista A, Garcia GF, White CC, Patel R, et al. HDAC inhibitors engage MITF and the disease-associated microglia signature to enhance amyloid \u03b2 uptake. Brain Behav Immun. 2025;129:279\u201393.","journal-title":"Brain Behav Immun"},{"key":"763_CR168","doi-asserted-by":"crossref","unstructured":"Ling L, Zhou G, Zhang X, Mao B, Wan S, Bao Y. A novel histone deacetylase inhibitor protects the blood-brain barrier by regulating NF-\u03baB and Nrf2 signaling pathways in OGD\/R injury. Arch Gerontol Geriatr. 2025;131.","DOI":"10.1016\/j.archger.2024.105739"},{"key":"763_CR169","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.3390\/ijms252212035","volume":"25","author":"Y Shen","year":"2024","unstructured":"Shen Y, Zhao J, Yang R, Yang H, Guo M, Ji B, et al. Panobinostat attenuates experimental autoimmune encephalomyelitis in mice via suppressing oxidative Stress-Related neuroinflammation and mitochondrial dysfunction. Int J Mol Sci. 2024;25:12035.","journal-title":"Int J Mol Sci"},{"key":"763_CR170","doi-asserted-by":"crossref","unstructured":"Xu L, An T, Jia B, Wu Q, Shen J, Jin J, et al. Histone deacetylase 3-specific inhibitor RGFP966 attenuates oxidative stress and inflammation after traumatic brain injury by activating the Nrf2 pathway. Burns Trauma. 2024;12.","DOI":"10.1093\/burnst\/tkad062"},{"key":"763_CR171","doi-asserted-by":"crossref","unstructured":"Davis N, Taylor B, Abelleira-Hervas L, Karimian-Marnani N, Aleksynas R, Syed N, et al. Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer\u2019s disease models. FASEB J. 2024;38.","DOI":"10.1096\/fj.202301762RR"},{"key":"763_CR172","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1021\/acschemneuro.1c00826","volume":"13","author":"W Sun","year":"2022","unstructured":"Sun W, Zhang N, Liu B, Yang J, Loers G, Siebert HC, et al. HDAC3 Inhibitor RGFP966 Ameliorated Neuroinflammation in the Cuprizone-Induced Demyelinating Mouse Model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R\/STAT3\/NF-\u03baB65\/NLRP3 Activation. ACS Chem Neurosci. 2022;13:2579\u201398.","journal-title":"ACS Chem Neurosci"},{"key":"763_CR173","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1126\/sciadv.abd8811","volume":"7","author":"S Wahane","year":"2021","unstructured":"Wahane S, Zhou X, Zhou X, Guo L, Friedl MS, Kluge M, et al. Diversified transcriptional responses of myeloid and glial cells in spinal cord injury shaped by HDAC3 activity. Sci Adv. 2021;7:8811\u201337.","journal-title":"Sci Adv"},{"key":"763_CR174","doi-asserted-by":"crossref","unstructured":"Jiang Z, Yang H, Ni W, Gao X, Pei X, Jiang H, et al. Attenuation of neuronal ferroptosis in intracerebral hemorrhage by inhibiting HDAC1\/2: microglial heterogenization via the Nrf2\/HO1 pathway. CNS Neurosci Ther. 2024;30.","DOI":"10.1111\/cns.14646"},{"key":"763_CR175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","volume":"381","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F, Liu S, Du J, Hu X, Xiong J, et al. Sodium butyrate exerts protective effect against parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci. 2017;381:176\u201381.","journal-title":"J Neurol Sci"},{"key":"763_CR176","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2016.03.003","volume":"618","author":"J Sun","year":"2016","unstructured":"Sun J, Wang F, Hong G, Pang M, Xu H, Li H, et al. Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress. Neurosci Lett. 2016;618:159\u201366.","journal-title":"Neurosci Lett"},{"key":"763_CR177","doi-asserted-by":"crossref","unstructured":"Wei H, Yu C, Zhang C, Ren Y, Guo L, Wang T, et al. Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis. Biomed Pharmacother. 2023;160.","DOI":"10.1016\/j.biopha.2023.114308"},{"key":"763_CR178","doi-asserted-by":"crossref","unstructured":"Park MJ, Sohrabji F. The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats. J Neuroinflammation. 2016;13.","DOI":"10.1186\/s12974-016-0765-6"},{"key":"763_CR179","doi-asserted-by":"crossref","unstructured":"Li Y, Liu A, Chen K, Li L, Zhang X, Zou F, et al. Sodium butyrate alleviates lead-induced neuroinflammation and improves cognitive and memory impairment through the ACSS2\/H3K9ac\/BDNF pathway. Environ Int. 2024;184.","DOI":"10.1016\/j.envint.2024.108479"},{"key":"763_CR180","doi-asserted-by":"crossref","unstructured":"Sun J, Lu L, Lian Y, Xu S, Zhu Y, Wu Y, et al. Sodium butyrate attenuates microglia-mediated neuroinflammation by modulating the TLR4\/MyD88\/NF-\u03baB pathway and microbiome-gut-brain axis in cardiac arrest mice. Mol Brain. 2025;18.","DOI":"10.1186\/s13041-025-01179-w"},{"key":"763_CR181","doi-asserted-by":"crossref","first-page":"116320","DOI":"10.1016\/j.bcp.2024.116320","volume":"225","author":"Y Meng","year":"2024","unstructured":"Meng Y, Xiao L, Liu R, Du J, Liu N, Yu J, et al. Antidepressant effect and mechanism of TMP269 on stress-induced depressive-like behavior in mice. Biochem Pharmacol. 2024;225:116320.","journal-title":"Biochem Pharmacol"},{"key":"763_CR182","doi-asserted-by":"crossref","first-page":"110319","DOI":"10.1016\/j.neuropharm.2025.110319","volume":"268","author":"AG O\u2019Mahony","year":"2025","unstructured":"O\u2019Mahony AG, Mazzocchi M, Morris A, Morales-Prieto N, Guinane C, Wyatt SL, et al. The class-IIa HDAC inhibitor TMP269 promotes BMP-Smad signalling and is neuroprotective in in vitro and in vivo 6-hydroxydopamine models of parkinson\u2019s disease. Neuropharmacology. 2025;268:110319.","journal-title":"Neuropharmacology"},{"key":"763_CR183","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.freeradbiomed.2011.12.006","volume":"52","author":"B Wang","year":"2011","unstructured":"Wang B, Zhu X, Kim Y, Li J, Huang S, Saleem S, et al. Histone deacetylase Inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med. 2011;52:928.","journal-title":"Free Radic Biol Med"},{"key":"763_CR184","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2011.06.016","volume":"44","author":"F Correa","year":"2011","unstructured":"Correa F, Mallard C, Nilsson M, Sandberg M. Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3\u03b2. Neurobiol Dis. 2011;44:142\u201351.","journal-title":"Neurobiol Dis"},{"key":"763_CR185","doi-asserted-by":"crossref","unstructured":"Peng C, Wang Y, Hu Z, Chen C. Selective HDAC6 Inhibition protects against blood-brain barrier dysfunction after intracerebral hemorrhage. CNS Neurosci Ther. 2024;30.","DOI":"10.1111\/cns.14429"},{"key":"763_CR186","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2013.06.043","volume":"1530","author":"S Danjo","year":"2013","unstructured":"Danjo S, Ishihara Y, Watanabe M, Nakamura Y, Itoh K. Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase. Brain Res. 2013;1530:44\u201353.","journal-title":"Brain Res"},{"key":"763_CR187","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1227\/NEU.0000000000001264","volume":"79","author":"GY Ying","year":"2016","unstructured":"Ying GY, Jing CH, Li JR, Wu C, Yan F, Chen JY, et al. Neuroprotective effects of valproic acid on blood-brain barrier disruption and apoptosis-related early brain injury in rats subjected to subarachnoid hemorrhage are modulated by heat shock protein 70\/matrix metalloproteinases and heat shock protein 70\/AKT. Neurosurgery. 2016;79:286\u201395.","journal-title":"Neurosurgery"},{"key":"763_CR188","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","volume":"31","author":"Z Wang","year":"2011","unstructured":"Wang Z, Leng Y, Tsai LK, Leeds P, Chuang DM. Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 Inhibition. J Cereb Blood Flow Metab. 2011;31:52\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"763_CR189","doi-asserted-by":"crossref","unstructured":"Hu QP, Mao DA. Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4\/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation. BMC Neurosci. 2016;17.","DOI":"10.1186\/s12868-016-0264-9"},{"key":"763_CR190","doi-asserted-by":"crossref","unstructured":"Hashioka S, Klegeris A, McGeer PL. The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-\u03b3. J Neuroinflammation. 2012;9.","DOI":"10.1186\/1742-2094-9-113"},{"key":"763_CR191","doi-asserted-by":"crossref","first-page":"116287","DOI":"10.1016\/j.biopha.2024.116287","volume":"172","author":"A D\u00edaz-P\u00e9rez","year":"2024","unstructured":"D\u00edaz-P\u00e9rez A, P\u00e9rez B, Manich G, Garc\u00eda-Aranda J, Navarro X, Penas C, et al. Histone deacetylase Inhibition by suberoylanilide hydroxamic acid during reperfusion promotes multifaceted brain and vascular protection in spontaneously hypertensive rats with transient ischaemic stroke. Biomed Pharmacother. 2024;172:116287.","journal-title":"Biomed Pharmacother"},{"key":"763_CR192","doi-asserted-by":"crossref","first-page":"e063223","DOI":"10.1002\/alz.063223","volume":"18","author":"Y Li","year":"2022","unstructured":"Li Y, Caulfield TR, Macyczko JR, Wang N, Jia L, Shue F, et al. Novel Wnt modulators for the treatment of alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2022;18:e063223.","journal-title":"Alzheimer\u2019s Dement"},{"key":"763_CR193","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/jth.14425","volume":"17","author":"X Cai","year":"2019","unstructured":"Cai X, Biswas I, Panicker SR, Giri H, Rezaie AR. Activated protein C inhibits lipopolysaccharide-mediated acetylation and secretion of high-mobility group box 1 in endothelial cells. J Thromb Haemost. 2019;17:803\u201317.","journal-title":"J Thromb Haemost"},{"key":"763_CR194","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12974-018-1388-x","volume":"15","author":"FY Liu","year":"2018","unstructured":"Liu FY, Cai J, Wang C, Ruan W, Guan GP, Pan HZ, et al. Fluoxetine attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage: a possible role for the regulation of TLR4\/MyD88\/NF-\u03baB signaling pathway. J Neuroinflammation. 2018;15:347.","journal-title":"J Neuroinflammation"},{"key":"763_CR195","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/npp.2014.73","volume":"39","author":"A Sarkar","year":"2014","unstructured":"Sarkar A, Chachra P, Kennedy P, Pena CJ, Desouza LA, Nestler EJ, et al. Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior. Neuropsychopharmacology. 2014;39:2221\u201332.","journal-title":"Neuropsychopharmacology"},{"key":"763_CR196","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bdi.12962","volume":"23","author":"M Taler","year":"2021","unstructured":"Taler M, Aronovich R, Henry Hornfeld S, Dar S, Sasson E, Weizman A, et al. Regulatory effect of lithium on hippocampal blood-brain barrier integrity in a rat model of depressive-like behavior. Bipolar Disord. 2021;23:55\u201365.","journal-title":"Bipolar Disord"},{"key":"763_CR197","doi-asserted-by":"crossref","first-page":"35500","DOI":"10.1074\/jbc.M113.479865","volume":"288","author":"S Wu","year":"2013","unstructured":"Wu S, Zheng S, Di, Huang HL, Yan LC, Yin XF, Xu HN, et al. Lithium Down-regulates histone deacetylase 1 (HDAC1) and induces degradation of mutant Huntingtin. J Biol Chem. 2013;288:35500\u201310.","journal-title":"J Biol Chem"},{"key":"763_CR198","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2009.64","volume":"34","author":"HM Wu","year":"2009","unstructured":"Wu HM, Tzeng NS, Qian L, Wei SJ, Hu X, Chen SH, et al. Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology. 2009;34:2344\u201357.","journal-title":"Neuropsychopharmacology"},{"key":"763_CR199","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cns.13580","volume":"27","author":"T Chen","year":"2021","unstructured":"Chen T, Liu WB, Qian X, Xie KL, Wang YH. The AMPAR antagonist perampanel protects the neurovascular unit against traumatic injury via regulating Sirt3. CNS Neurosci Ther. 2021;27:134\u201344.","journal-title":"CNS Neurosci Ther"},{"key":"763_CR200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mito.2013.12.003","volume":"14","author":"MC Chiang","year":"2014","unstructured":"Chiang MC, Cheng YC, Chen HM, Liang YJ, Yen CH. Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway. Mitochondrion. 2014;14:7\u201317.","journal-title":"Mitochondrion"},{"key":"763_CR201","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","volume":"125","author":"J Jin","year":"2013","unstructured":"Jin J, Albertz J, Guo Z, Peng Q, Rudow G, Troncoso JC, et al. Neuroprotective effects of PPAR-\u03b3 agonist Rosiglitazone in N171-82Q mouse model of huntington\u2019s disease. J Neurochem. 2013;125:410\u20139.","journal-title":"J Neurochem"},{"key":"763_CR202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12974-020-02028-4","volume":"17","author":"M Mota","year":"2020","unstructured":"Mota M, Porrini V, Parrella E, Benarese M, Bellucci A, Rhein S, et al. Neuroprotective epi-drugs quench the inflammatory response and microglial\/macrophage activation in a mouse model of permanent brain ischemia. J Neuroinflammation. 2020;17:361.","journal-title":"J Neuroinflammation"},{"key":"763_CR203","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1152\/jn.00510.2016","volume":"116","author":"D Wang","year":"2016","unstructured":"Wang D, Li SP, Fu JS, Zhang S, Bai L, Guo L. Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice. J Neurophysiol. 2016;116:2173\u20139.","journal-title":"J Neurophysiol"},{"key":"763_CR204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","volume":"30","author":"KS Shindler","year":"2010","unstructured":"Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A. Oral Resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol. 2010;30:328.","journal-title":"J Neuroophthalmol"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-026-00763-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-026-00763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:03:36Z","timestamp":1769137416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-026-00763-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":204,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1186\/s12987-026-00763-z","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}